Beijing Chunlizhengda Medical Instruments : NOTICE OF THE H SHAREHOLDERS' CLASS MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

北京市春立正達醫療器械股份有限公司

Beijing Chunlizhengda Medical Instruments Co., Ltd.*

(A joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1858)

NOTICE OF THE H SHAREHOLDERS' CLASS MEETING

Notice is hereby given that a class meeting of the holders of H shares (the "H Shareholders' Class Meeting") of Beijing Chunlizhengda Medical Instruments Co., Ltd.* (the "Company") will be held at 11:00 a.m. (or the time immediately after the conclusion of the Domestic Shareholders' Class Meeting) on Monday, 10 August 2020 or any adjournment thereof at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, the PRC, to consider and, if thought fit, to pass the following resolutions:

SPECIAL RESOLUTIONS

1. proposal of the A Share Offering;
2. 1. Class of Shares to be issued;
   2. Nominal value of Shares;
   3. Number of Shares to be issued;
   4. Pricing methodology;
   5. Method of issue;
   6. Target of subscribers;
   7. Form of underwriting;
   8. Place of listing; and
   9. Valid period of the resolution;
3. proposal on the use of proceeds from the Company's A Share Offering and feasibility analysis;
4. proposal on distribution of accumulated profits before the A Share Offering;

- 1 -

1. proposal on granting authorization to the Board and its authorized representatives to fully handle the specific matters in relation to the A Share Offering;
2. proposed amendments to the Articles of Association;

ORDINARY RESOLUTIONS

1. proposal on undertakings in connection with the matters about the A Share Offering and corresponding restrictive measures;
2. proposal on the analysis on remedying the impacts of the dilution of current return as a result of the A Share Offering and the responsive measures; and
3. proposal on the three-year shareholder dividend return plan after the A Share Offering.

By Order of the Board

Beijing Chunlizhengda Medical Instruments Co., Ltd.*

Shi Chunbao

Chairman

Beijing, the PRC

24 July 2020

• For identification purpose only

• Unless otherwise stated, the capitalized terms used herein shall have the same meanings as those defined in the circular of the Company dated 24 July 2020.

As at the date of this notice, the executive Directors of the Company are Mr. Shi Chunbao, Ms. Yue Shujun and Mr. Xie Feng Bao; the non-executive Director of the Company is Mr. Wang Xin; and the independent non-executive Directors of the Company are Mr. Ge Changyin, Mr. Ho Wai Ip and Mr. Weng Jie.

Notes:

1. REGISTRATION OF MEMBERS

In order to be qualified to attend and vote at the H Shareholders' Class Meeting, holders of H Shares whose transfers have not been registered must deposit the transfer documents together with the relevant share certificates at the office of the H Share registrar of the Company, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong by no later than 4:30 p.m. on Tuesday, 4 August 2020.

H Shareholders whose names appear on the Company's register of members at the close of business on Tuesday, 4 August 2020 are entitled to attend and vote at the H Shareholders' Class Meeting.

- 2 -

1. APPOINTMENT OF PROXY
   Any H Shareholder entitled to attend and vote at the H Shareholders' Class Meeting is entitled to appoint one or more proxies to attend and vote at the meeting instead of him/her. A proxy need not be a H Shareholder of the Company.
   The instrument to appoint a proxy shall be in writing and signed by the H Shareholder or of his/her attorney duly authorised in writing or, if the H Shareholder is a corporate body, either executed under its common seal or signed by its legal representative, director or duly authorised attorney. If the proxy form is signed by the attorney of the H Shareholder, the power of attorney or other authorisation document authorising the attorney to sign the proxy form must be notarised.
   To be valid, the proxy form, together with the power of attorney or other authority (if any), shall be lodged by hand or post, to the Company's H Share registrar in Hong Kong, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong, not less than 24 hours before the time appointed for holding the H Shareholders' Class Meeting or its adjourned meeting (as the case may be). Completion and return of the proxy form shall not preclude H Shareholders from attending and voting in person at the H Shareholders' Class Meeting.
2. REPLY SLIP
   H Shareholders who intend to attend in person or by proxy the H Shareholders' Class Meeting shall deliver the reply slip to the Company's H Share registrar in Hong Kong, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong, on or before Wednesday, 5 August 2020.
3. CONTACT PERSON OF THE COMPANY

Contact Person:	Mr. Zhao Guodao
Contact Tel:	(8610)	5861	1761/62/63
Contact Fax:	(8610)	5861	1751

1. PROCEDURES OF VOTING AT THE H SHAREHOLDERS' CLASS MEETING
   An H Shareholder or his/her/its proxy may exercise the right to vote by poll.
2. OTHERS
   The H Shareholders' Class Meeting is expected to take place immediately after the Domestic Shareholders' Class Meeting. H Shareholders attending the H Shareholders' Class Meeting (in person or by proxy) are responsible for their own transportation and accommodation fees.
   Identification documents must be shown by shareholder(s) or proxies to attend the H Shareholders' Class Meeting.

- 3 -